Menu Search
Equities

Danaher Corp

DHR:NYQ

Danaher Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)277.27
  • Today's Change5.37 / 1.97%
  • Shares traded757.84k
  • 1 Year change+22.56%
  • Beta0.8390
Data delayed at least 15 minutes, as of Sep 19 2024 17:15 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy6
Outperform12
Hold8
Sell1
Strong Sell0

Share price forecast in USD

The 21 analysts offering 12 month price targets for Danaher Corp have a median target of 285.00, with a high estimate of 310.00 and a low estimate of 236.00. The median estimate represents a 4.82% increase from the last price of 271.90.
High14.0%310.00
Med4.8%285.00
Low-13.2%236.00

Dividends in USD

In 2023, Danaher Corp reported a dividend of 1.06 USD, which represents a 10.42% increase over last year. The 11 analysts covering the company expect dividends of 1.09 USD for the upcoming fiscal year, an increase of 3.21%.
Div growth (TTM)10.42%
More ▼

Earnings history & estimates in USD

On Jul 23, 2024, Danaher Corp reported 2nd quarter 2024 earnings of 1.72 per share. This result exceeded the 1.57 consensus of the 20 analysts covering the company and under-performed last year's 2nd quarter results by 16.10%.
The next earnings announcement is expected on Oct 22, 2024.
Average growth rate-4.14%
Danaher Corp reported annual 2023 earnings of 7.58 per share on Jan 30, 2024.
Average growth rate+20.05%
More ▼

Revenue history & estimates in USD

Danaher Corporation had 2nd quarter 2024 revenues of 5.74bn. This bettered the 5.59bn consensus of the 19 analysts covering the company. This was 19.87% below the prior year's 2nd quarter results.
Average growth rate-5.30%
Danaher Corporation had revenues for the full year 2023 of 23.89bn. This was 24.09% below the prior year's results.
Average growth rate+9.84%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.